TuHURA Biosciences, Inc.
HURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498382
No open-market purchases or sales by TuHURA Biosciences, Inc. insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding TuHURA Biosciences, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 10 | 13 | +3 |
| Shares | 242.0K | 495.7K | +253.7K (+104.8%) |
| Value | $40.4K | $51.0K | +$10.6K (+26.3%) |
New holders (5)
Institutions that held TuHURA Biosciences, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 138,632 | $14.4K | 0.00% |
| Susquehanna International Group, LLP | 100,788 | $10.5K | 0.00% |
| HRT Financial LP | 81,604 | $8.00K | 0.00% |
| Jane Street Group, LLC | 69,361 | $7.21K | 0.00% |
| Qube Research & Technologies Ltd | 6,600 | $686 | 0.00% |
Sold out (2)
Institutions that held TuHURA Biosciences, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Stratos Wealth Partners, LTD. | 20,000 | $3.39K |
| Game Plan Financial Advisors, LLC | 40 | $7 |